Published in J Natl Cancer Inst on December 05, 2001
Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst (2001) 2.13
Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst (2000) 2.82
Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats. Gastroenterology (1995) 2.12
Radiation-induced division delay in Chinese hamster ovary fibroblast and carcinoma cells: dose effect and ploidy. Radiat Res (1981) 1.26
Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma. Histopathology (2006) 1.18
Chemoprevention for high-risk women: tamoxifen and beyond. Breast J (2002) 1.12
Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer (2005) 1.08
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women. Breast Cancer Res Treat (2011) 1.00
Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys (1990) 0.98
Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys (1987) 0.93
Bleomycin and brain tumors. A review. J Neurooncol (1983) 0.92
Choriocarcinoma, thyrotoxicosis, and the Klinefelter syndrome. Cancer Genet Cytogenet (1983) 0.91
Identification of a chemoprevention cohort from a population of women at high risk for breast cancer. J Cell Biochem Suppl (1996) 0.90
Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun (1988) 0.90
Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat Res (1993) 0.87
Radiation therapy of 9L rat brain tumors. Int J Radiat Oncol Biol Phys (1981) 0.87
A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry (1988) 0.86
Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung. Int J Radiat Oncol Biol Phys (1985) 0.85
Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity. Lupus (2008) 0.84
Comparison of the supravital DNA dyes Hoechst 33342 and DAPI for flow cytometry and clonogenicity studies of human leukemic marrow cells. Exp Hematol (1985) 0.84
Combination chemotherapy for the 9L rat brain tumor model system. Cancer Treat Rep (1982) 0.83
N-ethylmaleimide sensitization of X-irradiated hypoxic Chinese hamster cells. Radiat Res (1977) 0.83
Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann N Y Acad Sci (2001) 0.83
The effect of adriamycin and radiation on G2 progression. Cancer Res (1976) 0.83
Is there an adaptive response to radiation in the developing brain of the fetal rat? Radiat Res (1993) 0.82
The effect of N-ethylmaleimide on the response to x rays of synchronized HeLa cells. Radiat Res (1976) 0.82
Development and testing of new hypoxic cell radiosensitizers. Radiology (1979) 0.82
Models for early chemoprevention trials in breast cancer. Hematol Oncol Clin North Am (1998) 0.82
Alveolar macrophage proliferation in situ after thoracic irradiation of rats. Am Rev Respir Dis (1989) 0.81
Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study. J Clin Oncol (1985) 0.81
5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys (1991) 0.81
Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus (2006) 0.81
Opiate effects on 5-fluorouracil disposition in mice. Cancer Chemother Pharmacol (1997) 0.80
A phase I/II study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors. Int J Radiat Oncol Biol Phys (1990) 0.79
Progesterone-growth factor interactions in uterine stromal cells. Biol Reprod (1998) 0.79
Plasma levels and urinary excretion of methyl-GAG following iv infusion in man. Cancer Treat Rep (1981) 0.79
Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study. Cancer Res (1994) 0.79
Reduction of tumor necrosis factor-alpha bioactivity by a human ovarian epithelial cancer cell line in vitro. Am J Obstet Gynecol (1995) 0.79
Cyclic responses of cultured 9L cells to radiation. Radiat Res (1982) 0.79
Growth modulation of human leukemic, preleukemic, and myeloma progenitor cells by L-ascorbic acid. Am J Clin Nutr (1991) 0.79
Angiotensin-I-converting enzyme in cancer patients. J Clin Oncol (1984) 0.79
Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer. Breast Cancer Res Treat (1994) 0.78
Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials. J Cell Biochem Suppl (1997) 0.78
Hydroxyurea retards the progression of G2 cells. Exp Cell Res (1978) 0.78
Clonogenic assay combined with flow cytometric cell sorting for cell-cycle analysis of human leukemic colony-forming cells. Anticancer Res (1987) 0.78
Effect of corticosteroid treatment on cell recovery by lung lavage in acute radiation-induced lung injury. Radiat Res (1989) 0.78
Radioprotection of mice by dietary squalene. Lipids (1993) 0.78
Effects of omeprazole on cell kinetics of carcinogen-induced colon tumours in rats. Cell Prolif (1995) 0.78
Modification of radiation-induced division delay by caffeine analogues and dibutyryl cyclic AMP. Int J Radiat Biol Relat Stud Phys Chem Med (1982) 0.78
The effect of caffeine on radiation-induced division delay. Int J Radiat Biol Relat Stud Phys Chem Med (1977) 0.77
Lack of benefit of adjunctive chemotherapy in stage I malignant melanoma: a Southwest Oncology Group Study. Cancer Treat Rep (1987) 0.77
Mn[III] uroporphyrin I: a novel metalloporphyrin contrast agent for magnetic resonance imaging. Magn Reson Imaging (1991) 0.77
Lack of recovery from radiation-induced sublethal damage in human haematopoietic cells. Br J Cancer Suppl (1984) 0.77
Comparison of functional and morphological deficits in the rat after gestational exposure to ionizing radiation. Neurotoxicol Teratol (1989) 0.77
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study. Cancer (1983) 0.77
Comparison of the effects of dihydroxyanthraquinone and adriamycin on the survival of cultured Chinese hamster cells. Cancer Res (1982) 0.77
Induction of concentration-dependent blockade in the G2 phase of the cell cycle by cancer chemotherapeutic agents. Cancer Res (1978) 0.77
The effect of bleomycin and irradiation on G2 progression. Int J Radiat Oncol Biol Phys (1979) 0.77
In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes. Cancer Res (1992) 0.77
Hyperfractionation protects against long-term fibrosis in rat lung. Br J Cancer Suppl (1986) 0.76
Transit of normal rat uterine stromal cells through G1 phase of the cell cycle requires progesterone-growth factor interactions. Endocrinology (2000) 0.76
Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors. Int J Radiat Oncol Biol Phys (1993) 0.76
Heterogeneity of 5-fluorouracil radiosensitivity modulation in cultured mammalian cell lines. Int J Radiat Oncol Biol Phys (1992) 0.76
Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance. Cancer (1999) 0.76
Correlation of behavior with brain damage after in utero exposure to toxic agents. Neurotoxicol Teratol (1987) 0.76
Phase II study of chlorozotocin in islet cell carcinoma. A southwest Oncology Group study. Cancer Chemother Pharmacol (1983) 0.76
Radiation response of human normal and leukemic hemopoietic cells assayed by in vitro colony formation. Int J Radiat Oncol Biol Phys (1985) 0.76
Metallothionein-I transgenic mice are not protected from gamma-radiation. Toxicol Lett (1999) 0.76
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study. Cancer Treat Rep (1982) 0.75
Progressive behavioral changes in rats after exposure to low levels of ionizing radiation in utero. Neurotoxicol Teratol (1991) 0.75
125I-UDR induced division delay. Biophys J (1977) 0.75
Early effects of low doses of ionizing radiation on the fetal cerebral cortex in rats. Radiat Res (1990) 0.75
The search for new hypoxic cell radiosensitizers. J Natl Med Assoc (1980) 0.75
Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells. Invest New Drugs (1987) 0.75
Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture system. Invest New Drugs (1986) 0.75
Interaction of hyperthermia and radiation on the survival of synchronous 9L cells. Radiat Res (1982) 0.75
Interaction of razoxane and radiation on cultured Chinese hamster cells. Int J Radiat Oncol Biol Phys (1982) 0.75
Hyperthermia in cancer therapy. Kans Med (1986) 0.75
Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma. J Urol (1996) 0.75
Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial. Eur J Cancer (2000) 0.75
Flow cytometric analysis of the effects of high protein diet on isolated rat liver mitochondria. Cell Tissue Kinet (1988) 0.75
Interaction of radiation, dihydroxyanthraquinone, and adriamycin on the induction of acute lethality in mice. Int J Radiat Oncol Biol Phys (1984) 0.75
Correlation of the structure of amino-substituted anthraquinones to cytotoxicity in cultured Chinese hamster cells. Invest New Drugs (1983) 0.75
H2O and D2O sorption studies on spores of Bacillus megaterium. Radiat Res (1974) 0.75
Retrospective DNA ploidy analysis by image and flow cytometry in head and neck cancer. Laryngoscope (1996) 0.75
Effect of dihydroxyanthraquinone on the response of a rat solid tumor to radiation therapy. Am J Clin Oncol (1984) 0.75
Development of normal tissue damage in the rat subsequent to thoracic irradiation and prior treatment with cancer chemotherapeutic agents. Am J Clin Oncol (1984) 0.75
Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study. Cancer Treat Rep (1979) 0.75
Effect of dihydroxyanthraquinone (NSC 279836) and thoracic irradiation on long-term survival of rats. Cancer Res (1982) 0.75
Intraperitoneal bleomycin for ventriculoperitoneal spread of a hypothalamic astrocytoma. Cancer Drug Deliv (1986) 0.75
Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia. Cancer Clin Trials (1981) 0.75
Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating". Anticancer Res (1994) 0.75
Effect of dihydroxyanthraquinone (DHAQ) and radiation on the survival of cultured Chinese hamster ovary cells. Radiat Res (1983) 0.75
Total lymphoid irradiation retards evolution of articular erosions in collagen induced arthritis. J Rheumatol (1988) 0.75
Response of the 9L rat brain tumor to combination treatment with radiation and bleomycin. Int J Radiat Oncol Biol Phys (1981) 0.75
Ultrastructural evidence of cardiac damage resulting from thoracic irradiation and anthracyclines in the rat. Int J Radiat Oncol Biol Phys (1984) 0.75
Potentiation of rat brain tumor therapy by fluosol and carbogen. NCI Monogr (1988) 0.75
Modification of radiation and dihydroxyanthraquinone-induced cell lethality by cysteamine and N-ethylmaleimide. Int J Radiat Oncol Biol Phys (1984) 0.75
Fractionated sublethal total body irradiation and donor bone marrow infusion for induction of specific allograft tolerance. Transplant Proc (1981) 0.75